Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Atopic Eczema”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04626297
What this trial is testing

Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 254
Not applicableWithdrawnNCT04761978
What this trial is testing

Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
University Hospital, Lille
Large-scale testing (Phase 3)Looking for participantsNCT06807281
What this trial is testing

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Who this might be right for
Atopic Dermatitis
Pfizer 500
Post-approval studies (Phase 4)UnknownNCT03461302
What this trial is testing

Efficacy of Topical Coal Tar in Children With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Radboud University Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT07712536
What this trial is testing

Phase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 24
Large-scale testing (Phase 3)Looking for participantsNCT06461897
What this trial is testing

Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 675
Large-scale testing (Phase 3)Study completedNCT03912259
What this trial is testing

Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Sanofi 165
Large-scale testing (Phase 3)Study completedNCT02277769
What this trial is testing

Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Regeneron Pharmaceuticals 708
Large-scale testing (Phase 3)WithdrawnNCT04666675
What this trial is testing

Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil

Who this might be right for
Atopic Dermatitis (AD)
AbbVie
Testing effectiveness (Phase 2)Study completedNCT06436183
What this trial is testing

The Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisAtopicDermatitis+4 more
Apollo Therapeutics Ltd 62
Large-scale testing (Phase 3)Study completedNCT04345367
What this trial is testing

Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

Who this might be right for
Atopic Dermatitis
Pfizer 727
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07734415
What this trial is testing

Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisAtopic Dermatitis EczemaEczema
Inmagene LLC 400
Testing effectiveness (Phase 2)Study completedNCT03059693
What this trial is testing

Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Haus Bioceuticals 48
Not applicableStudy completedNCT06983561
What this trial is testing

Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients

Who this might be right for
Atopic Dermatitis
Pierre Fabre Dermo Cosmetique 80
Large-scale testing (Phase 3)Study completedNCT02835170
What this trial is testing

Study of Autologous Total Immunoglobulin G Therapy for Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Ajou University School of Medicine 51
Early research (Phase 1)Study completedNCT05197023
What this trial is testing

EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MULTIPLE SUBCUTANEOUS INJECTIONS OF SHR-1819 IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

Who this might be right for
Moderate to Severe Atopic Dermatitis
Shanghai Hengrui Pharmaceutical Co., Ltd. 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07465120
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Dermavon Holdings Limited 160
Testing effectiveness (Phase 2)UnknownNCT05702268
What this trial is testing

Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd. 75
Early research (Phase 1)Study completedNCT03826901
What this trial is testing

Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children

Who this might be right for
Atopic Dermatitis
LEO Pharma 46
Testing effectiveness (Phase 2)Study completedNCT03568162
What this trial is testing

Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Ichnos Sciences SA 462
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation